Emily M. Leproust

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
San Francisco, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Kendra Fox, as Attorney-in-Fact for Emily M. Leproust
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Emily M. Leproust

Form 4 holding Director

GeneDx Holdings Corp.

Security class
Restricted Stock Unit
Shares / value
12,924
Estimated value
$365,878
Report date
26 Jun 2024
Price
$28.31
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
Form 4 holding Chief Executive Officer, Director

Twist Bioscience Corp

Security class
Employee Stock Option (right to buy)
Shares / value
64,950
Estimated value
Report date
03 Aug 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
64,950

Insider Reports Filed by Emily M. Leproust

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .